CSL Limited_
Stock Overview
About
CSL Limited engages in the research, development, manufacture, market, and distribution of biopharmaceutical products and vaccines in Australia, the United States, Germany, the United Kingdom, Switzerland, China, Hong Kong, and internationally. The company operates through CSL Behring, CSL Seqirus, and CSL Vifor segments. The CSL Behring segment manufactures, markets, and distributes plasma products, gene therapies, and recombinants. This segment also offers therapies for people living with conditions in the immunology, hematology, cardiovascular and metabolic, respiratory, and transplant therapeutic areas. The CSL Seqirus segment manufactures, markets, and distributes influenza related products and pandemic services to governments. The CSL Vifor segment manufactures, markets, and distributes products in the therapeutic areas of iron deficiency and nephrology. It also licenses CSL intellectual property. CSL Limited was founded in 1916 and is headquartered in Melbourne, Australia.
Company Details
Frequently Asked Questions
What does CSL Limited do?
CSL Limited is a company in the Biotechnology industry. CSL Limited engages in the research, development, manufacture, market, and distribution of biopharmaceutical products and vaccines in Australia, the United States, Germany, the United Kingdom, Switzer
Where is CSL Limited headquartered?
CSL Limited is headquartered in Melbourne, VIC, Australia.
How many employees does CSL Limited have?
CSL Limited employs approximately 29,904 people worldwide.
Is CSL Limited publicly traded?
Yes, CSL Limited is a publicly traded company with the stock ticker symbol CSL.AX.
